首页> 外国专利> Drug insert for an implant to be inserted into a lacrimal canaliculus of a patient, method of manufacturing same and use of a drug insert to manufacture an implant for the treatment of glaucoma

Drug insert for an implant to be inserted into a lacrimal canaliculus of a patient, method of manufacturing same and use of a drug insert to manufacture an implant for the treatment of glaucoma

机译:用于将植入物插入患者泪小管中的植入物的药物插入物,其制造方法以及药物插入物用于制造用于治疗青光眼的植入物的用途

摘要

An implant for insertion into a punctum of a patient comprises a body. The body has a distal end, a proximal end, and an axis therebetween. The distal end of the body is insertable distally through the punctum into the canalicular lumen. The body comprises a therapeutic agent included within an agent matrix drug core. Exposure of the agent matrix to the tear fluid effects an effective therapeutics agent release into the tear fluid over a sustained period. The body has a sheath disposed over the agent matrix to inhibit release of the agent away from the proximal end. The body also has an outer surface configured to engage luminal wall tissues so as to inhibit expulsion when disposed therein. In specific embodiments, the agent matrix comprise a non-bioabsorbable polymer, for example silicone in a non-homogenous mixture with the agent.
机译:用于插入患者泪点的植入物包括身体。主体具有远端,近端以及其间的轴线。身体的远端可通过泪点向远端插入小管腔。身体包括包含在药剂基质药物核心内的治疗剂。试剂基质暴露于泪液会在持续时间内有效地将治疗剂释放到泪液中。主体具有设置在药剂基质上的护套,以抑制药剂从近端释放。主体还具有构造成与内腔壁组织接合的外表面,从而当被布置在其中时抑制排出。在特定的实施方案中,试剂基质包含不可生物吸收的聚合物,例如与试剂处于非均质混合物中的硅酮。

著录项

  • 公开/公告号IL212113A

    专利类型

  • 公开/公告日2017-04-30

    原文格式PDF

  • 申请/专利权人 QLT INC.;QLT PLUG DELIVERY INC;3088922 INC.;

    申请/专利号IL20110212113

  • 发明设计人

    申请日2011-04-03

  • 分类号A61K;

  • 国家 IL

  • 入库时间 2022-08-21 13:38:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号